Werlinich Asset Management, LLC Abbott Laboratories Transaction History

Werlinich Asset Management, LLC

$172 Billion
Q3 2024

A detailed history of Werlinich Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 13,695 shares of ABT stock, worth $1.58 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

13,695

Previous 13,595 0.74%

Holding current value

$1.58 Million

Previous $1.42 Billion 9.75%

% of portfolio

0.91%

Previous 0.89%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$100.07 - $118.13 $10,007 - $11,813	100 Added 0.74%	13,695 $1.56 Billion
Q2 2024 Jul 15, 2024	BUY	$100.73 - $112.44 $15,109 - $16,866	150 Added 1.12%	13,595 $1.42 Billion
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $547 - $604	-5 Reduced 0.04%	13,445 $1.53 Billion
Q4 2023 Jan 09, 2024	SELL	$90.19 - $110.4 $34,632 - $42,393	-384 Reduced 2.78%	13,450 $1.48 Billion
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $26,175 - $31,405	274 Added 2.02%	13,834 $1.34 Billion
Q2 2023 Nov 13, 2023	BUY	$100.78 - $112.29 $50,390 - $56,145	500 Added 3.83%	13,560 $1.48 Billion
Q1 2023 Nov 13, 2023	BUY	$96.86 - $114.01 $4,843 - $5,700	50 Added 0.38%	13,060 $1.32 Billion
Q4 2022 Nov 13, 2023	SELL	$95.06 - $111.52 $33,271 - $39,032	-350 Reduced 2.62%	13,010 $1.43 Billion
Q3 2022 Nov 13, 2023	SELL	$96.76 - $112.03 $19,352 - $22,406	-200 Reduced 1.47%	13,360 $1.29 Billion
Q1 2022 Nov 13, 2023	SELL	$114.02 - $139.04 $34,776 - $42,407	-305 Reduced 2.2%	13,560 $1.6 Billion
Q2 2021 Nov 13, 2023	BUY	$105.79 - $124.53 $10,579 - $12,453	100 Added 0.73%	13,865 $1.61 Billion
Q1 2021 Nov 13, 2023	BUY	$108.84 - $128.23 $1.5 Million - $1.77 Million	13,765 New	13,765 $1.65 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.

Account

Werlinich Asset Management, LLC Abbott Laboratories Transaction History